The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Longitudinal Analysis of Maternal Serum Leptin Levels during Pregnancy, at Birth and Up To Six Weeks after Birth: Relation to Body Mass Index, Skinfolds, Sex Steroids and Umbilical Cord Blood Leptin Levels
Abstract
Leptin is an important regulator of body fat mass and energy expenditure during adult life. The mechanisms by which maternal and fetal weight are regulated during pregnancy are poorly understood. In order to gain more insight into a potential role of leptin during gestation, a prospective, longitudinal study was carried out to measure leptin concentrations in maternal serum of 29 healthy women during pregnancy up to 6 weeks after birth and also in umbilical cord blood of their newborns. Leptin concentrations were measured using a specific RIA. In addition, estradiol, testosterone, and sex hormone binding globulin were determined using commercially available RIAs. The mothers’ skinfolds were determined at four sites using a Holtain caliper.Leptin levels increased continuously during pregnancy and reached 25.8 ± 14.7 ng/ml at 38–40 weeks. At birth, leptin concentrations were 23.5 ± 15.4 ng/ml. Three days after delivery a significant decrease of leptin levels to 10.6 ± 6.0 ng/ml was observed. Six weeks after birth the leptin concentration in maternal serum was 13.8 ± 8.6 ng/ml. At birth, maternal serum levels were significantly higher than levels in cord blood and did not correlate with leptin levels in cord blood or neonatal weight. Furthermore, leptin levels did not correlate with maternal sex steroids and sex hormone binding globulin levels. At 6–8 weeks of pregnancy, maternal leptin serum levels correlated significantly with BMI (r = 0.81). The correlation coefficients (leptin vs. BMI) dropped with increasing gestational age and at birth only a poor correlation persisted (r = 0.50). Six weeks after birth there was again a high correlation between leptin levels in maternal serum and BMI (r = 0.76). Subscapular skinfold thickness was correlated to leptin concentrations in maternal serum during the whole period of the investigation.In conclusion, maternal leptin levels continuously increased from 6–8 weeks up to 38–40 weeks of pregnancy. Maternal leptin levels decreased dramatically after birth. Six weeks after delivery, leptin levels were comparable to the values measured at the beginning of pregnancy. We hypothesize that leptin might play an important role during pregnancy and fetal development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effects of the obese Gene Product on Body Weight Regulation in ob / ob Mice
Pelleymounter, M. A., Cullen, M. J., Baker, M. B., Hecht, R., Winters, D., Boone, T., & Collins, F. (1995) · Science · doi:10.1126/science.7624776 · Cited by 4,017
Campfield, L. A., Smith, F. J., Guisez, Y., Devos, R., & Burn, P. (1995) · Science · doi:10.1126/science.7624778 · Cited by 3,243
Chen, H., Charlat, O., Tartaglia, L. A., Woolf, E. A., Weng, X., Ellis, S. J., Lakey, N. D., Culpepper, J., More, K. J., Breitbart, R. E., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81294-5 · Cited by 2,214
The role of neuropeptide Y in the antiobesity action of the obese gene product
Stephens, T. W., Basinski, M., Bristow, P. K., Bue-Valleskey, J. M., Burgett, S. G., Craft, L., Hale, J., Hoffmann, J., Hsiung, H. M., Kriauciunas, A., et al. (1995) · Nature · doi:10.1038/377530a0 · Cited by 1,498
Increased obese mRNA expression in omental fat cells from massively obese humans
Hamilton, B. S., Paglia, D., Kwan, A. Y. M., & Deitel, M. (1995) · Nature Medicine · doi:10.1038/nm0995-953 · Cited by 526
The alphabet of weight control.
Friedman, J. M. (1997) · Nature · doi:10.1038/385119a0 · Cited by 180 · cited 1×
“Little is known about the mechanisms by which maternal and fetal weight and fat mass are regulated during pregnancy. The ob protein, termed leptin, is produced by adipocytes and acts as an afferent satiety signal regulating appetite and weight both in humans and rodents [”
Background
Cited by
Integration of Metabolism and Intake Regulation: A Review Focusing on Periparturient Animals
Ingvartsen, K. L., & Andersen, J. B. (2000) · Journal of Dairy Science · doi:10.3168/jds.s0022-0302(00)75029-6 · Cited by 589
Leptin and reproduction: a review
Moschos, S., Chan, J. L., & Mantzoros, C. S. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(01)03010-2 · Cited by 557
Rasmussen, K. M., & Kjolhede, C. L. (2004) · Pediatrics · doi:10.1542/peds.113.5.e465 · Cited by 403
Abduljalil, K., Furness, P., Johnson, T. N., Rostami-Hodjegan, A., & Soltani, H. (2012) · Clinical Pharmacokinetics · doi:10.2165/11597440-000000000-00000 · Cited by 371
Leptin, adiponectin and other adipokines in gestational diabetes mellitus and pre‐eclampsia
Miehle, K., Stepan, H., & Fasshauer, M. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04234.x · Cited by 236
Increased Maternal Plasma Leptin in Early Pregnancy and Risk of Gestational Diabetes Mellitus
Qiu, C., Williams, M. A., Vadachkoria, S., Frederick, I. O., & Luthy, D. A. (2004) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000113621.53602.7a · Cited by 146
“Maternal leptin concentrations are known to increase 2- to 3-fold above nonpregnant concentrations, with the peak occurring around 28 weeks of gestation.(11) Results from clinical studies suggest that pregnancyassociated increases in maternal plasma leptin may result from an upregulation of adipocyte leptin synthesis…”
BackgroundAdipocytes and adipose tissue.
Kiess, W., Petzold, S., Töpfer, M., Garten, A., Blüher, S., Kapellen, T., Körner, A., & Kratzsch, J. (2008) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2007.10.002 · Cited by 130
Self-citation
Metadata
- Authors
- Schubring, C., Englaro, P., Siebler, T., Blum, W. F., Demirakca, T., Kratzsch, J., & Kiess, W.
- Venue
- Hormone Research in Paediatrics
- Publisher
- S. Karger AG
- Published
- 1998
- Volume
- 50
- Issue
- 5
- Pages
- 276-283
- ISSN
- 1663-2818 (ISSN-L)
- 1663-2826
- OpenAlex
- W2068609294
- Cited by
- 168
- References
- 6
- FWCI
- 1.89
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.